dr. shah on onartuzumab for gastroesophageal adenocarcinoma
Published 9 years ago • 87 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:12
dr. manish shah on onartuzumab for gastroesophageal adenocarcinoma
-
1:09
dr. manish shah on novel targets in gastric cancer
-
0:54
dr. shah on the trastuzumab biosimilar in gastric cancer
-
0:57
analyzing the destiny-gastric01 trial for gastric or gej adenocarcinoma
-
1:51
dr. shah on the heloise study for gastric cancer
-
1:30
dr. shah on the role of immunotherapy in gastroesophageal cancer
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma
-
1:54
exploring immunotherapy in patients with esophageal cancer
-
3:57
cancer of the esophagus - dr. manish a. shah
-
0:30
dr. grothey on trastuzumab for gastroesophageal cancer
-
22:31
targeted agents in gastric cancer - dr. manish a. shah
-
1:13
dr. shah discusses the brighter study in gastric cancer
-
0:53
dr. shah discusses challenges with immunotherapy in esophageal cancer
-
13:32
targeted therapy and immunotherapy for gastroesophageal cancer guideline
-
1:06
dr. manish shah on met inhibitors not improving pfs in met-positive gec
-
1:31
dr. shah highlights immunotherapy in esophageal cancer
-
4:52
frontline therapy approach for stage 4 gej cancer
-
13:46
2021 west oncology | gastrointestinal cancers | immuno-oncology in upper gi
-
2:20
systemic therapy and future of gej cancer treatment